Cyclopharma announces its participation in the annual EANM congress which takes place from the 21st to the 25th of October.
The European Association of Nuclear Medicine (EANM) is the umbrella organisation of nuclear medicine in Europe and represents the sector towards the European Institutions. Within this role, the EANM contributes to discussion and exchange of ideas and results relating to the diagnosis, treatment, research and prevention of diseases thanks to the nuclear medicine and promotes nuclear medicine for the benefit of public health.
The annual congress has become a forum for scientific exchange as well as for business, attracting about 6.200 participants. The congress is well established and recognised by the nuclear medicine sector.